| 8/11/2020 |
New Public Health Study Launches for At-Home COVID-19 Patient Experiences |
PR Newswire |
BOSTON iTakeControl Health is launching a new public health study, the COVID-19 @Home Patient Survey, for individuals who had COVID-19 and managed their illness and treatment primarily at home. The mobile-based IRB approved study is open to anyone 18 years of age or older with a suspected or confirmed case of COVID-19. The mobile app study consists of a survey and the option to contribute a ... |
| 6/11/2020 |
Patients as Partners US Relaunches Virtually and Globally |
PRWeb |
Patients as Partners US Relaunches Virtually and Globally Share Article The Conference Forum is pleased to announce the relaunch of the 7th annual Patients as Partners US conference in a live virtual format on August 19-21, 2020. Patients as Partners US “Relaunching on a virtual platform allows for more involvement from patients, biopharma, advocacy, academia and other stakeholders globally to demonstrate how patient engagement gets done,” Kate Woda, Conference Director ... |
| 12/20/2019 |
The Patients as Partners US Conference Announces 2020 Keynotes |
PRWeb |
The Patients as Partners US Conference Announces 2020 Keynotes Share Article The Conference Forum has announced the keynote speakers for the 7th annual Patients as Partners US event, taking place March 16-17 at the Hilton Philadelphia at Penn's Landing in Philadelphia, PA. Patients as Partners brings together biopharma, patients, advocacy and FDA to demonstrate the impact of engaging with patients throughout the drug development lifecycle to help create better clinical ... |
| 11/19/2019 |
Quality Cancer Care Alliance Network (QCCA) Selects Integra Connect as Preferred Population Health Analytics Partner |
PR Newswire |
WEST PALM BEACH, Fla. Integra Connect , the leading provider of technologies and services for value-based specialty care, today announced it has been selected by the Quality Cancer Care Alliance Network (QCCA), the first clinically integrated nationwide network of community oncology practices, as its preferred partner for population health analytics technology and to provide support for value-based care payment models. As a QCCA preferred partner, Integra Connect will offer ... |
| 7/22/2019 |
Meridian Clinical Research Acquires Regional Clinical Research of New York |
PRWeb |
Meridian Clinical Research Acquires Regional Clinical Research of New York Share Article Meridian Clinical Research has acquired Regional Clinical Research, expanding its North American footprint to more than 20 investigative sites. Meridian, which is celebrating its twentieth year in business, now supports more than 60 principal investigators. The acquisition also enhances Meridian’s existing therapeutic expertise in infectious diseases, neurology, and women’s health. Nicole Osborn, founder and CEO of Meridian, said ... |
| 6/11/2019 |
Gateway for Cancer Research Announces Recipient of 4th Annual Young Investigators Award |
PRWeb |
Gateway for Cancer Research Announces Recipient of 4th Annual Young Investigators Award Share Article Gateway for Cancer Research (Gateway), a non-profit dedicated to funding transformational cancer research, and the Conquer Cancer Foundation of the American Society of Clinical Oncologists (ASCO) have announced the recipient of the 2019 Young Investigators Award. The Young Investigator Award (YIA) provides funding to promising investigators to encourage and promote quality research in clinical oncology ... |
| 5/15/2019 |
FDA-Approved, Innovative Treatment for Glioblastoma (GMB) Cancer at West Cancer Center |
PR Newswire |
MEMPHIS, Tenn. , May 15, Being diagnosed with a Grade 3 anaplastic astrocytoma, a brain tumor in the left temporal lobe, at the age of 25, didn't stop Katherine (Katie) Stamps from living her life while managing this devastating disease. Working for the world's leading spine company, Medtronic has its rewards and her personal relationship with the top neurosurgeons in the country was one of many blessings that followed Katie's journey ... |
| 10/19/2017 |
Boehringer Ingelheim partners with TARGET PharmaSolutions to Progress NASH Research |
PR Newswire |
... modalities for NASH. This data, combined with the TARGET- NASH biorepository and patient reported outcomes, will enable our collaborators to continue to increase their understanding of this growing disease." Boehringer Ingelheim has a broad patient centric research and development program in metabolic diseases, encompassing diabetes as well as its contributing factors and complications. NASH is one of the company's key focus diseases in this therapy area with a high unmet ... |
| 10/19/2017 |
Boehringer Ingelheim partners with TARGET PharmaSolutions to Progress NASH Research |
PR Newswire |
... modalities for NASH. This data, combined with the TARGET- NASH biorepository and patient reported outcomes, will enable our collaborators to continue to increase their understanding of this growing disease." Boehringer Ingelheim has a broad patient centric research and development program in metabolic diseases, encompassing diabetes as well as its contributing factors and complications. NASH is one of the company's key focus diseases in this therapy area with a high unmet ... |